| 18 Mar 2010 01:16 | News-Medical.net |
StockPreacher.com announces an investment report featuring ACADIA Pharmaceuticals Inc (Nasdaq:ACAD). The report includes financial, comparative and investment analyses, and industry information ... more... |
| 17 Mar 2010 02:55 | Emailwire |
(EMAILWIRE.COM, March 16, 2010 ) Dallas, Tx - Following were among the Biotech companies whose shares were actively traded in Monday's session. CytRx Corporation (NASDAQ:CYTR) went up 5.08% to $1 ... more... |
| 10 Mar 2010 10:03 | Business Wire |
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel ... more... |
| 03 Mar 2010 03:04 | Business Wire |
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel ... more... |
| 02 Mar 2010 08:04 | Benzinga |
SmarTrend identified a Downtrend for Acadia Pharmaceuticals (NASDAQ: ACAD) on September 01, 2009 at $1.96. In approximately 6 months, Acadia Pharmaceuticals has returned 34.7% as of today's recent ... more... |